Literature DB >> 21499946

Postnatal trends in creatinemia and its covariates in extremely low birth weight (ELBW) neonates.

Isabel George1, Djalila Mekahli, Maissa Rayyan, Elena Levtchenko, Karel Allegaert.   

Abstract

To document trends and covariates of creatinemia (Scr) in extremely low birth weight (ELBW, < 1,000 g) neonates, maternal characteristics [betamethasone, premature preterm rupture of membranes (PPROM), pre-eclampsia, maternal Scr], characteristics at delivery [gestational age (GA), birth weight (BW), small for GA (SGA), Apgar, intubation] and during neonatal stay [ventilation, oxygen, parenteral nutrition, ibuprofen, steroids, intraventricular hemorrhage, retinopathy of prematurity (ROP), phototherapy] were linked with Scr observations. Data were reported by median and range or incidence. Characteristics in ELBW neonates with raised peak Scr (>P75) were compared to controls (<P75). In 151 ELBW neonates, an initial increase in Scr was observed, resulting in a peak Scr on day 3 or 4 of 99.9 (46.8-221.8) μmol/l with subsequent decrease. In cases (n  = 37) with a peak Scr >P75 (112.3 μmol/l), Scr remained elevated until day 28. Mothers of cases received less betamethasone, neonates had a lower GA, lower BW, lower Apgar, and needed more often intubation. Postnatal ventilation, oxygen, parenteral nutrition, ibuprofen, steroids, ROP, and intraventricular hemorrhage were different. GA and ventilation or Apgar were independent factors for raised peak Scr. ELBW neonates display trends similar to heavier neonates, but peak Scr is higher, and the subsequent decrease slower. Raised creatinemia in ELBW neonates reflects immaturity (GA) and morbidity (ventilation, Apgar).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21499946     DOI: 10.1007/s00467-011-1883-0

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  21 in total

1.  Renal function and volume of infants born with a very low birth-weight: a preliminary cross-sectional study.

Authors:  M Zaffanello; M Brugnara; C Bruno; B Franchi; G Talamini; G Guidi; L Cataldi; P Biban; R Mella; V Fanos
Journal:  Acta Paediatr       Date:  2010-03-14       Impact factor: 2.299

2.  The impact of ibuprofen on renal clearance in preterm infants is independent of the gestational age.

Authors:  Karel Allegaert; Veerle Cossey; Anne Debeer; Jean Paul Langhendries; Bart Van Overmeire; Jan de Hoon; Hugo Devlieger
Journal:  Pediatr Nephrol       Date:  2005-03-23       Impact factor: 3.714

3.  Postnatal renal function in preterm newborns: a role of diseases, drugs and therapeutic interventions.

Authors:  Laura Cuzzolin; Vassilios Fanos; Bernadette Pinna; Maria di Marzio; Monica Perin; Paola Tramontozzi; Paola Tonetto; Luigi Cataldi
Journal:  Pediatr Nephrol       Date:  2006-05-25       Impact factor: 3.714

4.  Glomerular filtration rate reference values in very preterm infants.

Authors:  Rachel Vieux; Jean-Michel Hascoet; Dana Merdariu; Jeanne Fresson; Francis Guillemin
Journal:  Pediatrics       Date:  2010-04-05       Impact factor: 7.124

Review 5.  Renal aspects of the term and preterm infant: a selective update.

Authors:  Alfred Drukker; Jean-Pierre Guignard
Journal:  Curr Opin Pediatr       Date:  2002-04       Impact factor: 2.856

6.  Why do newborn infants have a high plasma creatinine?

Authors:  J P Guignard; A Drukker
Journal:  Pediatrics       Date:  1999-04       Impact factor: 7.124

7.  Long-term follow-up of extremely low birth weight infants with neonatal renal failure.

Authors:  Carolyn L Abitbol; Charles R Bauer; Brenda Montané; Jayanthi Chandar; Shahnaz Duara; Gastón Zilleruelo
Journal:  Pediatr Nephrol       Date:  2003-06-27       Impact factor: 3.714

8.  A gestation- and postnatal age-based reference chart for assessing renal function in extremely premature infants.

Authors:  S Thayyil; S Sheik; S T Kempley; A Sinha
Journal:  J Perinatol       Date:  2008-02-21       Impact factor: 2.521

9.  Individualized dosing of aminoglycosides in neonates: mission accomplished or work in progress?

Authors:  John N van den Anker; Karel Allegaert
Journal:  Eur J Clin Pharmacol       Date:  2009-07-07       Impact factor: 2.953

10.  Renal drug clearance in preterm neonates: relation to prenatal growth.

Authors:  Karel Allegaert; Brian J Anderson; John N van den Anker; Sophie Vanhaesebrouck; Francis de Zegher
Journal:  Ther Drug Monit       Date:  2007-06       Impact factor: 3.681

View more
  19 in total

1.  Clinical pharmacology in neonates and young infants: the benefit of a population-tailored approach.

Authors:  John van den Anker; Karel Allegaert
Journal:  Expert Rev Clin Pharmacol       Date:  2012-01       Impact factor: 5.045

Review 2.  Pharmacokinetics in neonatal prescribing: evidence base, paradigms and the future.

Authors:  Kate O'Hara; Ian M R Wright; Jennifer J Schneider; Alison L Jones; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2015-10-26       Impact factor: 4.335

Review 3.  The interplay between drugs and the kidney in premature neonates.

Authors:  Michiel F Schreuder; Ruud R G Bueters; Karel Allegaert
Journal:  Pediatr Nephrol       Date:  2013-11-12       Impact factor: 3.714

4.  Clinical pharmacological studies in children: From exploratory towards confirmation driven methodology.

Authors:  Karel Allegaert
Journal:  World J Clin Pediatr       Date:  2012-08-08

Review 5.  Educational paper: Retinopathy of prematurity.

Authors:  Ingele Casteels; Catherine Cassiman; Joachim Van Calster; Karel Allegaert
Journal:  Eur J Pediatr       Date:  2011-11-04       Impact factor: 3.183

6.  Adverse drug reactions in neonates and infants: a population-tailored approach is needed.

Authors:  Karel Allegaert; Johannes N van den Anker
Journal:  Br J Clin Pharmacol       Date:  2015-06-01       Impact factor: 4.335

7.  Evaluating renal function and age as predictors of amikacin clearance in neonates: model-based analysis and optimal dosing strategies.

Authors:  Sílvia M Illamola; Helena Colom; J G Coen van Hasselt
Journal:  Br J Clin Pharmacol       Date:  2016-06-30       Impact factor: 4.335

8.  A neonatal amikacin covariate model can be used to predict ontogeny of other drugs eliminated through glomerular filtration in neonates.

Authors:  Roosmarijn F W De Cock; Karel Allegaert; Catherine M T Sherwin; Elisabet I Nielsen; Matthijs de Hoog; Johannes N van den Anker; Meindert Danhof; Catherijne A J Knibbe
Journal:  Pharm Res       Date:  2013-09-25       Impact factor: 4.200

9.  Recognition and reporting of AKI in very low birth weight infants.

Authors:  J Bryan Carmody; Jonathan R Swanson; Erika T Rhone; Jennifer R Charlton
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-03       Impact factor: 8.237

10.  Chronic inhibition of cGMP-specific phosphodiesterase 5 suppresses endoplasmic reticulum stress in heart failure.

Authors:  Wei Gong; Quanlu Duan; Zhejun Cai; Chen Chen; Li Ni; Mengwen Yan; Xingxu Wang; Katherine Cianflone; Dao Wen Wang
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.